Mayo Clinic Umbilical and Placental Tissues Biobank


About this study

The purpose of this study is to collect paired maternal and umbilical cord blood samples that can be processed for various traits in the blood, including serum, DNA, RNA and cells. The long term goal of this project is to start an Umbilical and Placental Tissues Biobank, which will operate in parallel to the Mayo Clinic Biobank. In future studies, we may use the serum, DNA and RNA obtained from cord blood and your blood to understand health and disease.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age 0 or older 
  • Females in the second or third trimester of pregnancy.
  • Females planning to deliver her infant at Mayo Clinic Rochester.
  • Females able and willing to provide informed consent.

Exclusion Criteria:

  • Females unable or unwilling to provide consent for self or infant.
  • Females planning to commercially or publically bank infant cord blood.


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Myra Wick, M.D., Ph.D.

Open for enrollment

Contact information:

Ann VanOosten


More information


Publications are currently not available